Inflammopharmacology

SCI SCIE

国际简称：INFLAMMOPHARMACOLOGY 参考译名：炎症药理学

主要研究方向：IMMUNOLOGYTOXICOLOGY-TOXICOLOGY 非预警期刊

《炎症药理学》(Inflammopharmacology)是一本由Springer International Publishing出版的以IMMUNOLOGYTOXICOLOGY-TOXICOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
445 年发文量
6.3 IF影响因子
未开放 是否OA
45 H-index
1991 创刊年份
6 issues per year 出版周期
English 出版语言

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states

-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs

-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents

-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain

-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs

-Muscle-immune interactions during inflammation [...]

[ 查看全部 ]

投稿咨询加急咨询

Inflammopharmacology期刊信息

ISSN：0925-4692
出版语言：English
是否OA：未开放
E-ISSN：1568-5608
出版地区：NETHERLANDS
是否预警：否
出版商：Springer International Publishing
出版周期：6 issues per year
创刊时间：1991
开源占比：0.128
Gold OA文章占比：20.41%
OA被引用占比：0.0576...
出版国人文章占比：0.15
出版撤稿占比：0
研究类文章占比：48.76%

Inflammopharmacology CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

8.7

1.373

1.302

学科类别	分区	排名	百分位
大类：Medicine 小类：Pharmacology (medical)	Q1	31 / 278	89%
大类：Medicine 小类：Pharmacology	Q1	50 / 328	84%
大类：Medicine 小类：Immunology	Q1	52 / 243	78%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Inflammopharmacology中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	IMMUNOLOGY 免疫学 TOXICOLOGY 毒理学	2区 1区

Inflammopharmacology JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	34 / 183	81.7
学科：TOXICOLOGY	SCIE	Q1	11 / 106	90.1
学科：IMMUNOLOGY	SCIE	Q1	36 / 183	80.6
学科：TOXICOLOGY	SCIE	Q1	16 / 106	85.38

Inflammopharmacology历年数据统计

影响因子

中科院分区

Inflammopharmacology中国学者发文选摘

1、Laminarin attenuates neuroinflammation in MPTP-induced parkinson's disease mouse model via inhibiting dectin-1/Syk/NF-κB signalin
Author: Zhao, Rui-Yue; Zhang, Mei; Wang, Xiao-Wen; Xue, Feng; Zheng, Yang-Yang; Chen, Wen-Fang

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. 34, Issue 4, pp. 2723-2733. DOI: 10.1007/s10787-026-02160-2
2、Interplay of oxidative stress and neuroinflammation in alzheimer's: insights into age-driven pathogenesi
Author: Firdous, Sayed Mohammad; Chakrabortty, Shibam; Undale, Vaishali R.; Mallik, Shouvik; Gouda, Mostafa

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. 34, Issue 4, pp. 2243-2263. DOI: 10.1007/s10787-026-02169-7
3、Luteolin in osteoarticular diseases: a review of preclinical studies and translational perspective
Author: Wang, Xia; Zeng, Liru; Zhou, Xiaoyu; Liu, Yuqi; Wang, Zixian; You, Shuqin; Wang, Yehong; Wang, Wenhong; Tian, Tingting; Huang, Xiao

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10787-026-02221-6
4、Efficacy of alpha-lipoic acid in mitigating neuropathic pain: mechanistic insights and therapeutic implication
Author: Dong, Daosong; Sun, Yanbin; Sui, Qingqing; Zhao, Zichen; Ma, Hong; Li, Kai; Yu, Xue

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. 34, Issue 3, pp. 1973-1990. DOI: 10.1007/s10787-026-02159-9
5、Non-covalent proteasome inhibitor PI1840 suppresses osteoclastogenesis and prevents LPS-induced osteolysis in mic
Author: Xia, Yehua; Zhao, Fuli; Dang, Cheng; Bai, Jiayi; Li, Yueqiang; Yang, Jiaxue; You, Qiuyi; Tang, Qiang; Dou, Wenwen; Liu, Mei

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10787-026-02175-9
6、The dual role of lipoteichoic acid: from immune modulation to therapeutic applications in disease treatmen
Author: Ding, Mingcong; Wang, Zhenshan; Xu, Linyu; Shi, Juan; Chen, Shuwei; Li, Qiang; Liu, Zixian

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10787-026-02130-8
7、Targeted delivery of curcumin based on nanocarriers: potential therapeutic strategies for noninfectious arthriti
Author: Cai, Baihui; Cai, Yiting; Wang, Han; Fang, Ruiying; Huang, Haiqiang; Zou, Mi; Chen, Bofan; Zeng, Haimin; Peng, Jie; Hao, Liang

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10787-026-02161-1
8、α-Pinene alleviates inflammatory responses and oxidative stress in freund's complete adjuvant induced arthritic rat model and associated risk factors of atherosclerosi
Author: Ali, Khadija; Iqral; Sharif, Ali; Akhtar, Bushra; Younas, Ayesha; Ali, Muhammad; Akhtar, Muhammad Furqan; Khan, Muhammad Imran; Al-Harrasi, Ahmed; Ahmad, Aftab

Journal: INFLAMMOPHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10787-026-02185-7